ABL1 G250E + ABL1 D276G + ABL1 T315I
|
ALL
|
ABL1 G250E + ABL1 D276G + ABL1 T315I
|
ALL
|
ponatinib Resistant: C4 – Case Studies
|
ponatinib Resistant: C4 – Case Studies
|
ABL1 G250E + ABL1 D276G + ABL1 T315I
|
ALL
|
ABL1 G250E + ABL1 D276G + ABL1 T315I
|
ALL
|
ponatinib + blinatumomab Sensitive: C4 – Case Studies
|
ponatinib + blinatumomab Sensitive: C4 – Case Studies
|